Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
The potential of MMP14 as a prognostic and immune biomarker in lung cancer
MMP14 RNA methylation levels positively correlated with mRNA expression.
»
01/17/26
Incidence, patterns of clinical presentation, and haematological characteristics of paediatric acute myeloid leukaemia in Uganda: a retrospective analysis
Significant differences in clinical characteristics by age.
»
01/19/26
Characterization of ESR1 alterations in patients with breast and gynecologic cancers
Evaluation of 21 therapeutically actionable biomarkers identified co-alterations in ESR1.
»
01/19/26
METTL3-mediated m6A modification of CACNA1E promotes osteosarcoma progression and chemoresistance by enhancing WNT7B-mediated Ca2+ signaling
CACNA1E knockdown effectively hindered OS growth.
»
01/19/26
Perceived exertion for guiding and monitoring exercise intensity in unsupervised, home-based cancer rehabilitation: an analysis of 3533 exercise sessions
Discrepancies between perceived and HR-based intensity systematically associated with age.
»
01/20/26
Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study
Higher proportion of patients in sCHT group did not initiate subsequent treatment.
»
01/20/26
Urinary miR-191-5p levels are significantly reduced after radical prostatectomy in patients with prostate cancer
Significant inverse correlation between expression of miR-191-5p and these genes in PCa tissues.
»
01/20/26
Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer
Efficacy of combination treatments with Paclitaxel and specific inhibitors of MET-NRF2 signalling assessed.
»
01/20/26
GLUT1 expression, lymphocyte distribution and CD3+ T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma
GLUT1 + melanoma regions contained significantly lower proportions of CD3
+
T-cells.
»
01/20/26
Assessment of the anticancer and antimetastatic effects of monocarbonyl analogs of curcumin, C66 and B2BrBC, in breast cancer cells
C66 and B2BrBC: enhanced stability compared to curcumin.
»
01/21/26
< Prev
Next >